Literature DB >> 16926131

Immune pathogenesis of paroxysmal nocturnal hemoglobinuria.

Ramon Tiu1, Jaroslaw Maciejewski.   

Abstract

Somatic mutation in the PIG-A gene is the initial event in the pathogenesis of paroxysmal nocturnal hemoglobinuria (PNH), but the pathophysiologic mechanisms leading to clonal expansion remain unclear. The intricate association of PNH with immune-mediated bone marrow failure syndromes, including aplastic anemia (AA), suggests an immunologic selection process for the glycosylphosphatidyl-inositol (GPI)-deficient hematopoietic clone. The mechanism for the growth advantage of PNH cells may be related to the nature of the antigens targeted by the immune response or to the function of immunomodulatory GPI-anchored proteins on the surface of the hematopoietic target cells. Alternative theories of PNH evolution may include intrinsic properties of the mutated cells, but the experimental evidence is largely lacking. Elucidation of the pathogenesis of PNH may provide key information about the causes of idiopathic AA and help understand the regulation of the hematopoietic stem cell compartment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926131     DOI: 10.1532/IJH97.06144

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  30 in total

1.  Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals.

Authors:  D J Araten; K Nafa; K Pakdeesuwan; L Luzzatto
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 2.  The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated.

Authors:  N S Young
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

Review 3.  Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology, and nature of the disease.

Authors:  J V Dacie; S M Lewis
Journal:  Ser Haematol       Date:  1972

4.  Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia.

Authors:  Chiharu Sugimori; Tatsuya Chuhjo; Xingmin Feng; Hirohito Yamazaki; Akiyoshi Takami; Masanao Teramura; Hideaki Mizoguchi; Mitsuhiro Omine; Shinji Nakao
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

5.  Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.

Authors:  D E Dunn; P Tanawattanacharoen; P Boccuni; S Nagakura; S W Green; M R Kirby; M S Kumar; S Rosenfeld; N S Young
Journal:  Ann Intern Med       Date:  1999-09-21       Impact factor: 25.391

6.  Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and "hypoplastic" leukemia have in common?

Authors:  W Dameshek
Journal:  Blood       Date:  1967-08       Impact factor: 22.113

7.  PIG-A mutations in normal hematopoiesis.

Authors:  Rong Hu; Galina L Mukhina; Steven Piantadosi; Jamie P Barber; Richard J Jones; Robert A Brodsky
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

8.  The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH).

Authors:  David J Araten; Lucio Luzzatto
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

9.  A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome.

Authors:  Yogen Saunthararajah; Ryotaro Nakamura; Robert Wesley; Qiong J Wang; A John Barrett
Journal:  Blood       Date:  2003-06-26       Impact factor: 22.113

10.  Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.

Authors:  Xingmin Feng; Tatsuya Chuhjo; Chiharu Sugimori; Takeharu Kotani; Xuzhang Lu; Akiyoshi Takami; Hiroyuki Takamatsu; Hirohito Yamazaki; Shinji Nakao
Journal:  Blood       Date:  2004-06-24       Impact factor: 22.113

View more
  3 in total

1.  SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.

Authors:  Manuel G Afable; Marcin Wlodarski; Hideki Makishima; Mohammed Shaik; Mikkael A Sekeres; Ramon V Tiu; Matt Kalaycio; Christine L O'Keefe; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

Review 2.  Transcriptional control of complement receptor gene expression.

Authors:  Brian K Martin
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

3.  Potential link between MHC-self-peptide presentation and hematopoiesis; the analysis of HLA-DR expression in CD34-positive cells and self-peptide presentation repertoires of MHC molecules associated with paroxysmal nocturnal hemoglobinuria.

Authors:  Jacek Nowak; Jolanta Wozniak; Ewa Mendek-Czajkowska; Agnieszka Dlugokecka; Renata Mika-Witkowska; Marta Rogatko-Koros; Elzbieta Graczyk-Pol; Anna Marosz-Rudnicka; Joanna Dziopa; Agnieszka Golec; Joanna Kopec-Szlezak; Krzysztof Warzocha
Journal:  Cell Biochem Biophys       Date:  2013-04       Impact factor: 2.194

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.